As of 2024-12-15, the EV/EBITDA ratio of Antares Pharma Inc (ATRS) is
13.69.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Antares's latest enterprise value
is 955.06 mil USD. Antares's TTM EBITDA according to its financial statements is
69.78 mil USD. Dividing these 2
quantities gives us the above Antares EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
9.4x - 12.7x |
11.4x |
| Forward P/E multiples |
15.6x - 18.8x |
17.5x |
| Fair Price |
3.84 - 10.17 |
7.06 |
| Upside |
-31.3% - 82.0% |
26.3% |